SCHEMBL14260752

SCHEMBL14260752

Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc3sc(C(=O)NO)cc3c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
MAPT P10636 1/20 0.58
CA12 O43570 3/20 0.53
CA9 Q16790 3/20 0.53
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA4 P22748 2/20 0.53
CA6 P23280 2/20 0.53
CA5A P35218 2/20 0.53
CA7 P43166 2/20 0.53
CA13 Q8N1Q1 2/20 0.53
CA14 Q9ULX7 2/20 0.53
TP53 P04637 1/20 0.53
HDAC1 Q13547 6/20 0.53
LMNA P02545 1/20 0.52
PPARG P37231 1/20 0.51
RAB9A P51151 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
NR2E3 Q9Y5X4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1888015 0.86 MAPT (0.77) MEN1KMT2AMAPTHDAC1LMNA
SCHEMBL14260712 0.82 MAPT (0.56) MEN1KMT2AMAPTCA12CA9
SCHEMBL6511964 0.80 HDAC1 (0.76) MEN1KMT2AMAPTHDAC1RAB9A
SCHEMBL8258861 0.78 MMP9 (0.55) MEN1KMT2AMAPTHDAC1
SCHEMBL3505877 0.78 MMP9 (0.55) MEN1KMT2AMAPTHDAC1
SCHEMBL14260745 0.77 CA12 (0.55) MEN1KMT2ACA12CA9CA1
SCHEMBL1884950 0.77 HDAC1 (0.78) MEN1KMT2AMAPTHDAC1LMNA
SCHEMBL6512630 0.77 HDAC1 (0.63) MEN1KMT2AMAPTHDAC1HDAC3
SCHEMBL1928662 0.76 CA12 (0.85) MEN1KMT2ACA12CA9CA1
SCHEMBL6243996 0.76 CA12 (0.85) MEN1KMT2ACA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 MEN1 2737/4885KMT2A 105/4885MAPT 4594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.